Parkinson's Trial NCT07148700
Find best test predicting falls
- Trial ID
- NCT07148700
- Official Title
- Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment
- Goal
- Find best test predicting falls
- Status
- COMPLETED
- Sponsor
- Bezmialem Vakif University
- Study Type
- OBSERVATIONAL
- Enrollment
- 40 participants
- Conditions
- PARKINSON DISEASE (Disorder), Parkinson, Parkinson s Disease, Parkinson Disease, Parkinson Disease (PD)
Summary For Families
The goal is to find which balance test best predicts how often people with Parkinson's fall. Participants will keep a fall diary while researchers compare three approaches: the Biodex Balance System, which gives objective measurements; the Falls Efficacy Scale-International, which asks how confident you feel doing everyday activities; and the Mini-Balance Evaluation Systems Test, which watches how you perform a range of balance tasks. The study is enrolling adults 40 to 80 years old with mild to moderate Parkinson's (Hoehn and Yahr stages 1 to 3) who are on stable Parkinson medication and score above 24 on a standard cognitive test. People with major vision, hearing, heart, or lung problems, recent unstable medical issues, or recent rehabilitation are not eligible.
Locations
- Bezmialem Vakif University, Istanbul, Eyup, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to find which balance test best predicts how often people with Parkinson's fall. Participants will keep a fall diary while researchers compare three approaches: the Biodex Balance System, which gives objective measurements; the Falls Efficacy Scale-International, which asks how confident you feel doing everyday activities; and the Mini-Balance Evaluation Systems Test, which watches how you perform a range of balance tasks. The study is enrolling adults 40 to 80 years old with mild to moderate Parkinson's (Hoehn and Yahr stages 1 to 3) who are on stable Parkinson medication and score above 24 on a standard cognitive test. People with major vision, hearing, heart, or lung problems, recent unstable medical issues, or recent rehabilitation are not eligible.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.